Showing results (291-300 of 449) with videos related to
Sort By:
Pageof 45
Biomedical Reports|July 15, 2015
Absence of telomerase reverse transcriptase promoter mutations in neuroblastomaSven Lindner, Hagen S Bachmann, Andrea Odersky, et al.Physical Review Letters|January 24, 2015
All-optical formation of coherent dark states of silicon-vacancy spins in diamondBenjamin Pingault, Jonas N Becker, Carsten H H Schulte, et al.Oncotarget|February 9, 2018
Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastomaViktor Arnhold, Karin Schmelz, Jutta Proba, et al.International Journal of Cancer|February 13, 2013
Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cellsKristian W Pajtler, Vera Rebmann, Monika Lindemann, et al.Molecular Cancer|May 28, 2023
IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expressionSven Hagemann, Danny Misiak, Jessica L Bell, et al.Journal of Synchrotron Radiation|December 22, 2011
The high-resolution diffraction beamline P08 at PETRA IIIO H Seeck, C Deiter, K Pflaum, et al.International Journal of Oral and Maxillofacial Surgery|October 9, 2013
Optimization of the interface between radiology, surgery, radiotherapy, and pathology in head and neck tumor surgery: a navigation-assisted multidisciplinary networkR Guijarro-Martínez, N-C Gellrich, J Witte, et al.Nucleic Acids Research|May 15, 2010
Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastomaJohannes H Schulte, Tobias Marschall, Marcel Martin, et al.Bone Marrow Transplantation|May 16, 2019
Haploidentical CD3 or α/β T-cell depleted HSCT in advanced stage sickle cell diseaseJuergen Foell, Johannes H Schulte, Beatrix Pfirstinger, et al.Oncogene|August 17, 2005
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profilingAlexander Schramm, Johannes H Schulte, Ludger Klein-Hitpass, et al.Pageof 45